Solid Biosciences, Inc. (SLDB)
6.92
-0.14
(-1.98%)
USD |
NASDAQ |
Oct 06, 16:00
6.91
-0.01
(-0.14%)
After-Hours: 20:00
Solid Biosciences Market Cap : 727.47M for Oct. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 727.47M |
| October 05, 2026 | 742.19M |
| October 02, 2026 | 720.11M |
| October 01, 2026 | 733.78M |
| September 30, 2026 | 760.06M |
| September 29, 2026 | 752.70M |
| September 28, 2026 | 765.31M |
| September 25, 2026 | 766.36M |
| September 24, 2026 | 786.34M |
| September 23, 2026 | 843.11M |
| September 22, 2026 | 937.72M |
| September 21, 2026 | 897.77M |
| September 18, 2026 | 936.67M |
| September 17, 2026 | 932.46M |
| September 16, 2026 | 916.69M |
| September 15, 2026 | 879.90M |
| September 14, 2026 | 918.80M |
| September 11, 2026 | 914.59M |
| September 10, 2026 | 953.49M |
| September 09, 2026 | 1.003B |
| September 08, 2026 | 1.044B |
| September 04, 2026 | 1.078B |
| September 03, 2026 | 1.095B |
| September 02, 2026 | 1.081B |
| September 01, 2026 | 1.039B |
| Date | Value |
|---|---|
| August 31, 2026 | 1.007B |
| August 28, 2026 | 1.027B |
| August 27, 2026 | 1.065B |
| August 26, 2026 | 1.022B |
| August 25, 2026 | 1.040B |
| August 24, 2026 | 962.95M |
| August 21, 2026 | 977.67M |
| August 20, 2026 | 956.64M |
| August 19, 2026 | 1.024B |
| August 18, 2026 | 954.54M |
| August 17, 2026 | 956.64M |
| August 14, 2026 | 967.15M |
| August 13, 2026 | 954.54M |
| August 12, 2026 | 952.96M |
| August 11, 2026 | 930.36M |
| August 10, 2026 | 899.87M |
| August 07, 2026 | 882.00M |
| August 06, 2026 | 915.64M |
| August 05, 2026 | 917.74M |
| August 04, 2026 | 906.18M |
| August 03, 2026 | 789.13M |
| July 31, 2026 | 793.06M |
| July 30, 2026 | 835.37M |
| July 29, 2026 | 791.09M |
| July 28, 2026 | 784.21M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 319.19M |
| Amgen, Inc. | 217.65B |
| BioCryst Pharmaceuticals, Inc. | 2.029B |
| Imunon, Inc. | 5.226M |
| Curis, Inc. | 1.460M |
Market Cap Related Metrics
| Price to Book Value | 1.945 |
| Price | 6.92 |
| Earnings Yield | -27.58% |